Compare Novo Nordisk A/S (NVO) vs Wayfair Inc (W) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Wayfair Inc — how do they compare? Novo Nordisk A/S trades at $45.89 (market cap $207.85B), while Wayfair Inc trades at $104.76 (market cap $14.14B). The key difference: Novo Nordisk A/S is far larger — about 14.7× Wayfair Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Wayfair Inc pays none. Which is the better fit depends on your goals.
| NVO | W | |
|---|---|---|
Market Cap | $207.85B | $14.14B |
Sector | Health | Consumer Cyclical |
52-Week High | $63.98 | $119.05 |
52-Week Low | $35.29 | $57.40 |
Enterprise Value | $222.55B | $16.47B |
Dividend Yield | 3.81% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Wayfair Inc
Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →
